1. Home
  2. AORT vs CENT Comparison

AORT vs CENT Comparison

Compare AORT & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • CENT
  • Stock Information
  • Founded
  • AORT 1984
  • CENT 1955
  • Country
  • AORT United States
  • CENT United States
  • Employees
  • AORT N/A
  • CENT N/A
  • Industry
  • AORT Medical/Dental Instruments
  • CENT Consumer Specialties
  • Sector
  • AORT Health Care
  • CENT Consumer Discretionary
  • Exchange
  • AORT Nasdaq
  • CENT Nasdaq
  • Market Cap
  • AORT 1.9B
  • CENT 2.2B
  • IPO Year
  • AORT 1993
  • CENT N/A
  • Fundamental
  • Price
  • AORT $40.55
  • CENT $30.70
  • Analyst Decision
  • AORT Strong Buy
  • CENT Strong Buy
  • Analyst Count
  • AORT 6
  • CENT 2
  • Target Price
  • AORT $43.13
  • CENT $42.50
  • AVG Volume (30 Days)
  • AORT 422.4K
  • CENT 87.7K
  • Earning Date
  • AORT 11-06-2025
  • CENT 11-24-2025
  • Dividend Yield
  • AORT N/A
  • CENT N/A
  • EPS Growth
  • AORT N/A
  • CENT N/A
  • EPS
  • AORT N/A
  • CENT 2.14
  • Revenue
  • AORT $405,037,000.00
  • CENT $3,120,375,000.00
  • Revenue This Year
  • AORT $14.99
  • CENT N/A
  • Revenue Next Year
  • AORT $10.80
  • CENT $0.16
  • P/E Ratio
  • AORT N/A
  • CENT $14.47
  • Revenue Growth
  • AORT 7.44
  • CENT N/A
  • 52 Week Low
  • AORT $21.97
  • CENT $30.73
  • 52 Week High
  • AORT $45.07
  • CENT $43.88
  • Technical
  • Relative Strength Index (RSI)
  • AORT 47.87
  • CENT 19.79
  • Support Level
  • AORT $38.95
  • CENT $31.88
  • Resistance Level
  • AORT $41.59
  • CENT $32.86
  • Average True Range (ATR)
  • AORT 1.04
  • CENT 0.73
  • MACD
  • AORT -0.27
  • CENT -0.27
  • Stochastic Oscillator
  • AORT 42.50
  • CENT 1.85

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About CENT Central Garden & Pet Company

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: